{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:32:17Z","timestamp":1782448337435,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.placenta.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:28:00Z","timestamp":1729816080000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: A prospective cohort study"],"prefix":"10.1016","volume":"158","author":[{"given":"Nora Hersoug","family":"Nedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Nystad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Therese","family":"Ahlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirin Listau","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Guz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Uhrynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"D\u0119bska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gierszon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Orzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Husebekk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Brojer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cathrine","family":"Staff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-0750","authenticated-orcid":false,"given":"Heidi","family":"Tiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.placenta.2024.10.014_bib1","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1111\/1471-0528.15642","article-title":"Prenatal management of pregnancies at risk of fetal neonatal alloimmune thrombocytopenia (FNAIT): scientific impact paper No. 61","volume":"126","author":"Regan","year":"2019","journal-title":"Bjog"},{"key":"10.1016\/j.placenta.2024.10.014_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.placenta.2024.10.014_bib3","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.placenta.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0412.2011.01269.x","article-title":"Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys","volume":"91","author":"Tiller","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2024.10.014_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104168","article-title":"What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - new insights from a large prospective screening study in Poland","volume":"160","author":"Coucheron","year":"2023","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2024.10.014_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.placenta.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/aogs.14421","article-title":"Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women","volume":"101","author":"Xue","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"12","key":"10.1016\/j.placenta.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/S2352-3026(23)00271-5","article-title":"Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study","volume":"10","author":"de Vos","year":"2023","journal-title":"The Lancet Haematology"},{"key":"10.1016\/j.placenta.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.placenta.2021.07.291","article-title":"Platelet alloimmunization is associated with low grade chronic histiocytic intervillositis - a new link to a rare placental lesion?","volume":"112","author":"Nedberg","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.placenta.2016.10.009","article-title":"Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: a retrospective cohort study of 21 cases","volume":"48","author":"Dubruc","year":"2016","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","article-title":"Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia","volume":"8","author":"Yougbare","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V72.1.230.230","article-title":"Alloantigenic composition of the endothelial vitronectin receptor","volume":"72","author":"Giltay","year":"1988","journal-title":"Blood"},{"issue":"Pt 1","key":"10.1016\/j.placenta.2024.10.014_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj2800009","article-title":"A vitronectin-receptor-related molecule in human placental brush border membranes","volume":"280","author":"Vanderpuye","year":"1991","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"17","key":"10.1016\/j.placenta.2024.10.014_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12175492","article-title":"Pregnant women at low risk of having a child with fetal and neonatal alloimmune thrombocytopenia do not require treatment with intravenous immunoglobulin","volume":"12","author":"Kjeldsen-Kragh","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.13274","article-title":"Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage","volume":"56","author":"Delbos","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.placenta.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04408.x","article-title":"European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia","volume":"122","author":"Birchall","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1537-2995.2007.01063.x","article-title":"Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study","volume":"47","author":"Killie","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.placenta.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1538-7836.2006.01809.x","article-title":"Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia","volume":"4","author":"Bertrand","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2s","key":"10.1016\/j.placenta.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4 Suppl","key":"10.1016\/j.placenta.2024.10.014_bib24","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl","key":"10.1016\/j.placenta.2024.10.014_bib25","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ijmm.2023.5292","article-title":"Predictive value of the sFlt-1\/PlGF ratio in women with suspected preeclampsia: an update (review)","volume":"52","author":"Velegrakis","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.placenta.2024.10.014_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.placenta.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/1471-0528.17151","article-title":"Angiogenic factors for planning fetal surveillance in fetal growth restriction and small-for-gestational-age fetuses: a prospective observational study","volume":"129","author":"Bonacina","year":"2022","journal-title":"Bjog"},{"issue":"2s","key":"10.1016\/j.placenta.2024.10.014_bib29","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1016\/j.ajog.2017.12.002","article-title":"Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers","volume":"218","author":"Gaccioli","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/aogs.13978","article-title":"Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age","volume":"100","author":"Garcia-Manau","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2024.10.014_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19009","article-title":"Fetal and neonatal alloimmune thrombocytopenia: No evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key?","author":"B\u00f6hm","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.placenta.2024.10.014_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.5114\/aoms.2016.63600","article-title":"Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a","volume":"14","author":"Debska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.placenta.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.transci.2003.10.004","article-title":"Evaluation of a new flow cytometric HPA 1a screening method- A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women","volume":"30","author":"Killie","year":"2004","journal-title":"Transfus. Apher. Sci."},{"issue":"6","key":"10.1016\/j.placenta.2024.10.014_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-3148.2004.00538.x","article-title":"Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSP method","volume":"14","author":"Ficko","year":"2004","journal-title":"Transfus. Med."},{"issue":"6","key":"10.1016\/j.placenta.2024.10.014_bib35","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.placenta.2024.10.014_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.transci.2010.07.001","article-title":"Quantitative MAIPA: comparison of different MAIPA protocols","volume":"43","author":"Killie","year":"2010","journal-title":"Transfus. Apher. Sci."},{"issue":"2","key":"10.1016\/j.placenta.2024.10.014_bib37","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.placenta.2024.10.014_bib39","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1080\/01443615.2022.2109956","article-title":"sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study","volume":"42","author":"Bonacina","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.placenta.2024.10.014_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1034\/j.1600-0412.2000.079006440.x","article-title":"Birthweight by gestational age in Norway","volume":"79","author":"Skjaerven","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"10","key":"10.1016\/j.placenta.2024.10.014_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/1471-0528.12128","article-title":"Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?","volume":"120","author":"Myatt","year":"2013","journal-title":"Bjog"},{"issue":"4","key":"10.1016\/j.placenta.2024.10.014_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang."},{"issue":"7","key":"10.1016\/j.placenta.2024.10.014_bib43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.placenta.2024.10.014_bib44","doi-asserted-by":"crossref","first-page":"239.e1","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2024.10.014_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total versus free placental growth factor levels in the pathogenesis of preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.placenta.2024.10.014_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1469-7580.2008.00978.x","article-title":"Oxygen, the Janus gas; its effects on human placental development and function","volume":"215","author":"Burton","year":"2009","journal-title":"J. Anat."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424006878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424006878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:24:36Z","timestamp":1733991876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400424006878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S0143400424006878"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2024.10.014","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}